You'll see manufacturers market more metabolites and isomers of existing drugs to replace drugs with expiring patents
You'll see manufacturers market more metabolites and isomers of existing drugs to replace drugs with expiring patents.
The pitch is often that the active isomer or metabolite will give better efficacy...or fewer side effects.
Some new products live up to these expectations...some don't.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: MD includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote